Medication review at hospital discharge is not cost-effective in highly vulnerable patients

Background

[1]  G. Nijpels,et al.  Amsterdam tool for clinical medication review: development and testing of a comprehensive tool for pharmacists and general practitioners , 2015, BMC Research Notes.

[2]  G. Nijpels,et al.  Effect of a pharmacist medication review in elderly patients discharged from the hospital. , 2012, Archives of internal medicine.

[3]  J. D. de Gier,et al.  Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. , 2012, British journal of clinical pharmacology.

[4]  J. Ramsberg,et al.  A cost-effectiveness analysis of an in-hospital clinical pharmacist service , 2012, BMJ Open.

[5]  C. Cardwell,et al.  A Cluster Randomized Controlled Trial of an Adapted U.S. Model of Pharmaceutical Care for Nursing Home Residents in Northern Ireland (Fleetwood Northern Ireland Study): A Cost‐Effectiveness Analysis , 2011, Journal of the American Geriatrics Society.

[6]  A. Bueno-Cavanillas,et al.  Drug-related problems in older people after hospital discharge and interventions to reduce them. , 2010, Age and ageing.

[7]  L. Welschen,et al.  Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial , 2010, BMC public health.

[8]  Cordula Wagner,et al.  Direct medical costs of adverse events in Dutch hospitals , 2009, BMC health services research.

[9]  R. Garrick,et al.  Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands , 2009 .

[10]  D Bajpai,et al.  Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study , 2007, BMC clinical pharmacology.

[11]  Stirling Bryan,et al.  Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data , 2007, Clinical trials.

[12]  R. Holland,et al.  Home-based medication review in older people: is it cost effective? , 2007, PharmacoEconomics.

[13]  Jennifer L. Kirwin,et al.  Role of pharmacist counseling in preventing adverse drug events after hospitalization. , 2006, Archives of internal medicine.

[14]  L. Shepstone,et al.  Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial , 2005, BMJ : British Medical Journal.

[15]  M. Bouvy,et al.  Drug related problems identified by European community pharmacists in patients discharged from hospital , 2004, Pharmacy World and Science.

[16]  Nick Freemantle,et al.  Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice , 2001, BMJ : British Medical Journal.

[17]  J. Krska,et al.  Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. , 2001, Age and ageing.

[18]  S. Thompson,et al.  How should cost data in pragmatic randomised trials be analysed? , 2000, BMJ : British Medical Journal.

[19]  L. Kohn,et al.  COMMITTEE ON QUALITY OF HEALTH CARE IN AMERICA , 2000 .

[20]  S D Small,et al.  The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. , 1998, JAMA.

[21]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[22]  H. Cohen,et al.  A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. , 1996, The American journal of medicine.

[23]  Bradley Efron,et al.  Missing Data, Imputation, and the Bootstrap , 1994 .

[24]  B. Adamcik,et al.  The Pharmacist’s Role in Rational Drug Therapy of the Aged , 1993, Drugs & aging.

[25]  Roger A. Sugden,et al.  Multiple Imputation for Nonresponse in Surveys , 1988 .